SCHEMBL20955977

SCHEMBL20955977

Clc1ccc2cccn2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.50
RAB9A P51151 11/20 0.36
NPC1 O15118 9/20 0.36
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 6/20 0.36
PKM P14618 1/20 0.36
PDE10A Q9Y233 1/20 0.34
ALDH1A2 O94788 1/20 0.34
ALDH1A3 P47895 1/20 0.34
GLA P06280 1/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
GRM5 P41594 1/20 0.33
SMN1; SMN2 Q16637 6/20 0.32
MAPT P10636 4/20 0.32
POLB P06746 3/20 0.32
LMNA P02545 2/20 0.32
CYP2A6 P11509 1/20 0.32
MEN1 O00255 2/20 0.32
KMT2A Q03164 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9517185 0.74 ALOX15 (0.48) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL276215 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL276216 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL2008456 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL2008459 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL24097278 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL4566858 0.71 ALOX15 (0.50) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL1607479 0.68
SCHEMBL7479399 0.68 ALOX15 (1.00) ALOX15RAB9ANPC1ALDH1A1KDM4E
SCHEMBL29089761 0.67 ALDH1A1 (0.62) ALOX15RAB9ANPC1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026087899-A1 MODULATORS OF THE GPR17 RECEPTOR NXERA PHARMA UK LIMITED (GB) 2026-04-30 WO disclosed
US-20230391763-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY EVOTEC INTERNATIONAL GMBH (DE) 2023-12-07 US disclosed
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-11685756-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-06-27 US disclosed
US-20220056063-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2022-02-24 US disclosed
US-11214587-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-01-04 US disclosed
US-11214587-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2022-01-04 US disclosed
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-05-09 US disclosed
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2019-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11685756-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 ALOX15 1268/4885RAB9A 1983/4885NPC1 3147/4885
US-20220056063-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OPRD1 ALOX15 1268/4885RAB9A 1983/4885NPC1 3147/4885
US-20230391763-A1 MODULATORS OF THE INTEGRATED STRESS RESPONSE PATHWAY CRH, AVPR1B, CRHR2 ALOX15 3273/4885RAB9A 2719/4885NPC1 1720/4885
US-11214587-B2 Organic electroluminescent materials and devices OCIAD1, OCIAD2, OPRD1 ALOX15 1268/4885RAB9A 1983/4885NPC1 3147/4885
US-20190135843-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD1, OCIAD2, OPRD1 ALOX15 1268/4885RAB9A 1983/4885NPC1 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.